tradingkey.logo

Supernus Pharmaceuticals Inc

SUPN
51.650USD
+2.280+4.62%
Close 02/06, 16:00ETQuotes delayed by 15 min
2.95BMarket Cap
LossP/E TTM

Supernus Pharmaceuticals Inc Earnings Date

Period
FY2024 Earnings Date
Revenue(YoY)
661.82M
8.94%
EPS(YoY)
1.34
5455.57%
Analyst Rating
BUY
2026-02-06

Financial Indicators

EPS
Revenue
Net Profit
Net Margin
Gross Margin
Debt to assets ratio
ROE
ROA
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Income Statement

Revenue
Operating profit
Net Profit
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Balance Sheet

Current assets
Total current liabilities
Total assets
Total liabilities
Total equity
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.

Cash Flow Statement

Net operating income
Net investment
Net financing
Currency: USD
Quarterly
Quarterly
Annual
Relevant data have not been disclosed by the company yet.
KeyAI